Petmed Express Stock Alpha and Beta Analysis
| PETS Stock | USD 4.42 0.12 2.79% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as PetMed Express. It also helps investors analyze the systematic and unsystematic risks associated with investing in PetMed Express over a specified time horizon. Remember, high PetMed Express' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to PetMed Express' market risk premium analysis include:
Beta 0.97 | Alpha 0.0476 | Risk 4.92 | Sharpe Ratio 0.0128 | Expected Return 0.0628 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
PetMed |
PetMed Express Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. PetMed Express market risk premium is the additional return an investor will receive from holding PetMed Express long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PetMed Express. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate PetMed Express' performance over market.| α | 0.05 | β | 0.97 |
PetMed Express expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of PetMed Express' Buy-and-hold return. Our buy-and-hold chart shows how PetMed Express performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.PetMed Express Market Price Analysis
Market price analysis indicators help investors to evaluate how PetMed Express stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PetMed Express shares will generate the highest return on investment. By understating and applying PetMed Express stock market price indicators, traders can identify PetMed Express position entry and exit signals to maximize returns.
PetMed Express Return and Market Media
The median price of PetMed Express for the period between Sun, Dec 1, 2024 and Sat, Mar 1, 2025 is 4.91 with a coefficient of variation of 9.77. The daily time series for the period is distributed with a sample standard deviation of 0.48, arithmetic mean of 4.96, and mean deviation of 0.36. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | PetMeds Adopts Limited Duration Shareholder Rights Plan | 12/03/2024 |
2 | Acquisition by Campbell Leslie C.g. of 10000 shares of PetMed Express at 5. subject to Rule 16b-3 | 12/04/2024 |
3 | Acquisition by Campbell Leslie C.g. of 5000 shares of PetMed Express at 5.42 subject to Rule 16b-3 | 12/05/2024 |
4 | Acquisition by Nina Capital Holdings Inc. of 32000 shares of PetMed Express at 5.655 subject to Rule 16b-3 | 12/16/2024 |
5 | Acquisition by Bruce Rosenbloom of 9775 shares of PetMed Express at 31.2 subject to Rule 16b-3 | 12/27/2024 |
6 | Acquisition by Nina Capital Holdings Inc. of 25000 shares of PetMed Express at 4.975 subject to Rule 16b-3 | 01/07/2025 |
7 | Petmed Express sees 124,374 stock purchase by Nina Capital Holdings - Investing.com | 01/10/2025 |
8 | Acquisition by Jacqueline Smith of 8000 shares of PetMed Express subject to Rule 16b-3 | 01/15/2025 |
9 | PetMed Express Share Price Passes Above Two Hundred Day Moving Average - Should You Sell - MarketBeat | 01/22/2025 |
10 | Acquisition by Nina Capital Holdings Inc. of 25000 shares of PetMed Express at 4.947 subject to Rule 16b-3 | 01/24/2025 |
11 | Acquisition by Nina Capital Holdings Inc. of 25000 shares of PetMed Express at 4.635 subject to Rule 16b-3 | 01/27/2025 |
12 | Petmed Express sees 239,550 in stock purchases by major shareholders - MSN | 01/28/2025 |
13 | Acquisition by Nina Capital Holdings Inc. of 25000 shares of PetMed Express at 4.82 subject to Rule 16b-3 | 02/03/2025 |
14 | What To Expect From PetMed Express Inc Q3 2025 Earnings | 02/07/2025 |
15 | PetMedsAnnounces Third Quarter Fiscal 2025 Financial Results | 02/10/2025 |
16 | PetMed Express Inc Q3 2025 Earnings Call Highlights Navigating Challenges with ... | 02/11/2025 |
17 | PetMed Express Downgraded to Hold Rating by StockNews.com | 02/12/2025 |
18 | 3 US Penny Stocks With Market Caps Under 200M | 02/20/2025 |
About PetMed Express Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including PetMed or other stocks. Alpha measures the amount that position in PetMed Express has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 (projected) | Dividend Yield | 0.0745 | 0.13 | Price To Sales Ratio | 1.28 | 0.34 |
PetMed Express Upcoming Company Events
As portrayed in its financial statements, the presentation of PetMed Express' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PetMed Express' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of PetMed Express' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of PetMed Express. Please utilize our Beneish M Score to check the likelihood of PetMed Express' management manipulating its earnings.
| 5th of February 2024 Upcoming Quarterly Report | View | |
| 27th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of May 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with PetMed Express
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.